These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1628371)

  • 1. Pharmacokinetics and tumor concentration of intraarterial and intravenous cisplatin in patients with head and neck squamous cancer.
    Sileni VC; Fosser V; Maggian P; Padula E; Beltrame M; Nicolini M; Arslan P
    Cancer Chemother Pharmacol; 1992; 30(3):221-5. PubMed ID: 1628371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition and tumour concentrations of platinum in hypoalbuminaemic patients after treatment with cisplatin for cancer of the head and neck.
    Holding JD; Lindup WE; Bowdler DA; Siodlak MZ; Stell PM
    Br J Clin Pharmacol; 1991 Aug; 32(2):173-9. PubMed ID: 1931468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of liposomal cisplatin (lipoplatin) in combination with 5-FU in patients with advanced head and neck cancer: first results of a phase III study.
    Jehn CF; Boulikas T; Kourvetaris A; Possinger K; Lüftner D
    Anticancer Res; 2007; 27(1A):471-5. PubMed ID: 17352269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of intra-arterial and intravenous cisplatin in head and neck cancer patients.
    Gouyette A; Apchin A; Foka M; Richard JM
    Eur J Cancer Clin Oncol; 1986 Mar; 22(3):257-63. PubMed ID: 3709595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of intra-arterial and intravenous infusion of cisplatin for head and neck squamous cell carcinoma in a modified rat model.
    Moses BL; Chan DW; Hruban RH; Forastiere A; Richtsmeier WJ
    Arch Otolaryngol Head Neck Surg; 1993 Jun; 119(6):612-7. PubMed ID: 8499090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamics of 5-fluorouracil combined with carboplatin in patients with head and neck cancer.
    Wihlm J; Leveque D; Klein T
    Anticancer Res; 1994; 14(6A):2395-6. PubMed ID: 7825979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous infusion high-dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck.
    Dreyfuss AI; Clark JR; Wright JE; Norris CM; Busse PM; Lucarini JW; Fallon BG; Casey D; Andersen JW; Klein R
    Ann Intern Med; 1990 Feb; 112(3):167-72. PubMed ID: 2297193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of cisplatin, 5-fluorouracil and folinic acid using a weekly 24-h infusion schedule for locally advanced head and neck cancer: a pharmacokinetic and clinical survey.
    Riva C; Lavieille JP; Schmerber S; Cuisnie O; Reyt E
    Int J Oncol; 2000 Sep; 17(3):543-9. PubMed ID: 10938396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics of plasma and cerebrospinal fluid cisplatin in patients with malignant glioma and metastatic brain tumor after selective intraarterial or intravenous and intracarotid administration of etoposide and cisplatin].
    Nakagawa H; Miyawaki Y; Tokiyoshi K; Tsuruzono K; Yamada M; Kanayama T; Hayakawa T
    No Shinkei Geka; 1994 Jan; 22(1):35-42. PubMed ID: 8295700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study.
    Schena M; Barone C; Birocco N; Dongiovanni D; Numico G; Colantonio I; Bertetto O
    Cancer Chemother Pharmacol; 2005 Mar; 55(3):271-6. PubMed ID: 15592837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Super high-dose intraarterial cisplatin infusion under percutaneous pelvic perfusion with extracorporeal chemofiltration for advanced uterine cervical carcinoma: I. Analysis for pharmacokinetics, tumor response, and toxicity of platinum.
    Hamana S; Motoyama S; Takeuchi S; Ku Y; Yoshida S; Miyahara Y; Tateiwa Y; Maruo T
    Am J Clin Oncol; 2001 Jun; 24(3):241-6. PubMed ID: 11404493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of two dosages and schedules of ifosfamide in combination with cisplatin in neo-adjuvant chemotherapy of patients with advanced (stage III-IV) head and neck squamous cell carcinoma: a phase II randomized study.
    Mantovani G; Ghiani M; Lai P; Maccio A; Dessi D; Succu G; Massa D; Curreli L; Mulas C; Esu S; Proto E; Cadeddu G; Tore G
    Oncol Rep; 1998; 5(6):1499-505. PubMed ID: 9769395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin pharmacokinetics and pharmacodynamics in patients with squamous-cell carcinoma of the head/neck or esophagus.
    Johnsson A; Höglund P; Grubb A; Cavallin-Ståhl E
    Cancer Chemother Pharmacol; 1996; 39(1-2):25-33. PubMed ID: 8995496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer.
    Taylor SG; Murthy AK; Vannetzel JM; Colin P; Dray M; Caldarelli DD; Shott S; Vokes E; Showel JL; Hutchinson JC
    J Clin Oncol; 1994 Feb; 12(2):385-95. PubMed ID: 8113846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of cisplatin, fluorouracil, and pure folinic acid for locally advanced head and neck cancer: a pharmacokinetic and clinical survey.
    Schneider M; Etienne MC; Milano G; Thyss A; Otto J; Dassonville O; Mobayen H; Saudes L; Guillot T; Demard F
    J Clin Oncol; 1995 Jul; 13(7):1656-62. PubMed ID: 7602355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective intra-arterial infusion of high-dose cisplatin in patients with advanced head and neck cancer results in high tumor platinum concentrations and cisplatin-DNA adduct formation.
    Los G; Blommaert fA; Barton R; Heath DD; den Engelse L; Hanchett C; Vicario D; Weisman R; Robbins KT; Howell SB
    Cancer Chemother Pharmacol; 1995; 37(1-2):150-4. PubMed ID: 7497585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between fluorouracil systemic exposure and tumor response and patient survival.
    Milano G; Etienne MC; Renée N; Thyss A; Schneider M; Ramaioli A; Demard F
    J Clin Oncol; 1994 Jun; 12(6):1291-5. PubMed ID: 8201391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I trial of retinoic acid and cis-platinum for advanced squamous cell cancer of the head and neck based on experimental evidence of drug synergism.
    Weisman RA; Christen R; Los G; Jones V; Kerber C; Seagren S; Glassmeyer S; Orloff LA; Wong W; Kirmani S; Howell S
    Otolaryngol Head Neck Surg; 1998 May; 118(5):597-602. PubMed ID: 9591856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Superselective intra-arterial infusion therapy with docetaxel, cisplatin and 5-fluorouracil for head and neck cancer--for tongue cancer patients in comparison patients with other therapies].
    Furusaka T
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1241-6. PubMed ID: 16969018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective randomized trial of high-dose cisplatin and fluorouracil infusion with or without sodium diethyldithiocarbamate in recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Paredes J; Hong WK; Felder TB; Dimery IW; Choksi AJ; Newman RA; Castellanos AM; Robbins KT; McCarthy K; Atkinson N
    J Clin Oncol; 1988 Jun; 6(6):955-62. PubMed ID: 2836565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.